ConAlliance has a unique blend of industry expertise in Ophthalmics, combined with a history of transactional success.

In recent years, the ophthalmology sector has witnessed relatively vigorous M&A activity. The increasingly aging global population and other trends are expected to sustain market growth in ophthalmology, thereby accelerating corporate acquisitions by strategists and investors.

This segment of Ophthalmics comprises medical devices ranging from intraocular lenses and contact lenses (including lens care products) to surgical devices (such as those for glaucoma, cataract, vitreoretinal, or refractive procedures), ophthalmic surgical instruments, ophthalmic lasers (e.g., microkeratomes), ophthalmic viscoelastic devices (OVDs), and extends to artificial tears and ocular lubricants. Attraktive companies in this space have focused, for example, on the application of innovative optical technologies to preserve and enhance vision.

ConAlliance possesses outstanding advisory expertise and numerous references in ophthalmology, enabling us to guarantee the swift execution of our mandates and the optimal M&A transaction or due diligence process. Contact us to discuss how we can assist you in achieving your strategic objectives.